Loss of RB compromises specific heterochromatin modifications and modulates HP1α dynamics
Abstract
Heterochromatin domains are important for gene silencing, centromere organization, and genomic stability. These genomic domains are marked with specific histone modifications, heterochromatin protein 1 (HP1) binding and DNA methylation. The retinoblastoma tumor suppressor, RB mediates transcriptional repression and functionally interacts with a number of factors that are involved in heterochromatin biology including HP1, Suv39h1, DNMT1, and components of the SWI/SNF chromatin remodeling complex. To analyze the specific influence of RB loss on chromatin modification, mouse adult fibroblasts (MAFs) derived from RbloxP/loxP mice were utilized to acutely knockout RB. In this setting, target genes of RB are deregulated. Additionally, changes in histone modifications were observed. Specifically, histone H4 lysine 20 trimethylation was absent from heterochromatin domains following loss of RB and there were changes in the relative levels of histone modifications between RB‐proficient and deficient cells. While RB loss significantly altered the modifications associated with heterochromatin domains, these domains were readily identified and efficiently mediated the recruitment of HP1α. Kinetic analyses of HP1α within the heterochromatin domains present in RB‐deficient cells indicated that loss of RB retarded HP1α dynamics, indicating that HP1α is paradoxically more tightly associated with heterochromatin in the absence of RB function. Combined, these analyses demonstrate that loss of RB has global effects on chromatin modifications and dynamics. J. Cell. Physiol. 211: 131–137, 2007. © 2007 Wiley‐Liss, Inc.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Loss of RB function may alter the epigenetic definition of the genome through misregulation of chromatin remodelling enzymes and DNA modifiers.
“loss of RB function might also alter the epigenetic definition of the genome through misregulation of chromatin remodelling enzymes117 and DNA modifiers.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [117]
Cites
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1× · see citing works
“Subsequent studies have indicated that RB plays an active role in senescence-induced heterochromatin foci in human cells (Narita et al., 2003).”
BackgroundDifferential role of RB in response to UV and IR damage
Bosco, E. E. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki283 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974 · see citing works
Mandel, S., & Gozes, I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704756200 · Cited by 150 · see citing works
- Authors
- Siddiqui, H., Fox, S. R., Gunawardena, R. W., & Knudsen, E. S.
- Affiliations
- University of Cincinnati (US)
- Corresponding author
- Siddiqui, Hasan
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2007-01-23
- Volume
- 211
- Issue
- 1
- Pages
- 131-137
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2141028091
- Cited by
- 47
- References
- 2
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2019: 3 · 2018: 1 · 2016: 3 · 2015: 2 · 2014: 5 · 2013: 1 · 2012: 2
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Albert J. Ryan Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Cancer Institute (CA 104213-02, R01CA104213)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- retinoblastoma protein, heterochromatin, HP1α, histone modifications, H4K20 trimethylation, chromatin dynamics, gene silencing, centromere organization, genome stability, SUV39H1, DNMT1, SWI/SNF chromatin remodeling, transcriptional repression
- MeSH terms
- Chromobox Protein Homolog 5, Animals, Chromosomal Proteins, Non-Histone, Fibroblasts, Genetic Markers, Heterochromatin, Histones, Retinoblastoma Protein, Euchromatin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review